Literature DB >> 17039453

Use of a modified-live vaccine to prevent persistent testicular infection with bovine viral diarrhea virus.

M Daniel Givens1, Kay P Riddell, Yijing Zhang, Patricia K Galik, David A Stringfellow, Bruce W Brodersen, James A Jackson, Michael A Ellsworth, Martin D Ficken, Robert L Carson, James G W Wenzel, M Shonda Marley.   

Abstract

A commercial vaccine containing modified-live bovine viral diarrhea virus (BVDV; types 1 and 2) was administered to one group of 22 peripubertal bulls 28 days before intranasal inoculation with a type 1 strain of BVDV. A second group of 23 peripubertal bulls did not receive the modified-live BVDV vaccine before intranasal inoculation. Ten of 23 unvaccinated bulls--but none of the vaccinated bulls--developed a persistent testicular infection as determined by immunohistochemistry and polymerase chain reaction. Results of this study indicate that administration of a modified-live vaccine containing BVDV can prevent persistent testicular infection if peripubertal bulls are vaccinated before viral exposure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17039453

Source DB:  PubMed          Journal:  Vet Ther        ISSN: 1528-3593


  2 in total

1.  Evaluation of transmission of bovine viral diarrhea virus (BVDV) between persistently infected and naive cattle by the horn fly (Haematobia irritans).

Authors:  Manuel F Chamorro; Thomas Passler; M Daniel Givens; Misty A Edmondson; Dwight F Wolfe; Paul H Walz
Journal:  Vet Res Commun       Date:  2010-12-07       Impact factor: 2.459

2.  Bovine viral diarrhea virus: An updated American College of Veterinary Internal Medicine consensus statement with focus on virus biology, hosts, immunosuppression, and vaccination.

Authors:  Paul H Walz; Manuel F Chamorro; Shollie M Falkenberg; Thomas Passler; Frank van der Meer; Amelia R Woolums
Journal:  J Vet Intern Med       Date:  2020-07-07       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.